Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Anti-disease therapy for malaria - 'resistance proof'?

Bell A, Boehm D.

Curr Pharm Des. 2013;19(2):300-6. Review.

PMID:
22973884
2.

Targeting host factors to circumvent anti-malarial drug resistance.

Prudêncio M, Mota MM.

Curr Pharm Des. 2013;19(2):290-9. Review.

PMID:
22973886
3.

The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum.

Le Bras J, Durand R.

Fundam Clin Pharmacol. 2003 Apr;17(2):147-53. Review.

PMID:
12667224
4.

The need for new antimalarial drugs less prone to resistance.

Noedl H.

Curr Pharm Des. 2013;19(2):266-9. Review.

PMID:
22973887
5.
6.

Helicases - feasible antimalarial drug target for Plasmodium falciparum.

Tuteja R.

FEBS J. 2007 Sep;274(18):4699-704. Review.

7.

Proteases of malaria parasites: new targets for chemotherapy.

Rosenthal PJ.

Emerg Infect Dis. 1998 Jan-Mar;4(1):49-57. Review.

8.

The fight against drug-resistant malaria: novel plasmodial targets and antimalarial drugs.

Choi SR, Mukherjee P, Avery MA.

Curr Med Chem. 2008;15(2):161-71. Review.

PMID:
18220771
9.

In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin.

Sidhu AB, Sun Q, Nkrumah LJ, Dunne MW, Sacchettini JC, Fidock DA.

J Biol Chem. 2007 Jan 26;282(4):2494-504. Epub 2006 Nov 15.

10.

Antimalarial drug resistance and early drug discovery.

Garcia-Bustos JF, Gamo FJ.

Curr Pharm Des. 2013;19(2):270-81. Review.

PMID:
22973885
11.

Malarial parasites vs. antimalarials: never-ending rumble in the jungle.

Mordmüller B, Kremsner PG.

Curr Mol Med. 2006 Mar;6(2):247-51. Review.

PMID:
16515514
12.

Antimalarial drug therapy: the role of parasite biology and drug resistance.

Daily JP.

J Clin Pharmacol. 2006 Dec;46(12):1487-97. Review.

PMID:
17101748
13.

Molecular and biological aspects of antimalarial resistance in Plasmodium falciparum and Plasmodium vivax.

Bustamante C, Batista CN, Zalis M.

Curr Drug Targets. 2009 Mar;10(3):279-90. Review.

PMID:
19275564
14.

Malaria, anti malarial drugs and the role of melatonin.

Srinivasan V, Mohamed M, Zakaria R, Ahmad AH.

Infect Disord Drug Targets. 2012 Oct;12(5):371-9. Review.

PMID:
23082960
15.

A class of potent antimalarials and their specific accumulation in infected erythrocytes.

Wengelnik K, Vidal V, Ancelin ML, Cathiard AM, Morgat JL, Kocken CH, Calas M, Herrera S, Thomas AW, Vial HJ.

Science. 2002 Feb 15;295(5558):1311-4.

16.

Pre-treatment with chloroquine and parasite chloroquine resistance in Ghanaian children with severe malaria.

Evans JA, May J, Tominski D, Eggelte T, Marks F, Abruquah HH, Meyer CG, Timmann C, Agbenyega T, Horstmann RD.

QJM. 2005 Nov;98(11):789-96. Epub 2005 Sep 26.

PMID:
16186171
17.

Is there any artemisinin resistance in falciparum malaria?

Treeprasertsuk S, Viriyavejakul P, Silachamroon U, Vannphan S, Wilairatana P, Looareesuwan S.

Southeast Asian J Trop Med Public Health. 2000 Dec;31(4):825-8.

PMID:
11414435
18.

Selective inhibition of an apicoplastic aminoacyl-tRNA synthetase from Plasmodium falciparum.

Hoen R, Novoa EM, López A, Camacho N, Cubells L, Vieira P, Santos M, Marin-Garcia P, Bautista JM, Cortés A, Ribas de Pouplana L, Royo M.

Chembiochem. 2013 Mar 4;14(4):499-509. doi: 10.1002/cbic.201200620.

PMID:
23444099
19.

History and current status of Plasmodium falciparum antimalarial drug resistance in Madagascar.

Andriantsoanirina V, Ménard D, Tuseo L, Durand R.

Scand J Infect Dis. 2010;42(1):22-32. doi: 10.3109/00365540903289670. Review.

PMID:
19883158
20.

Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay.

Linares M, Viera S, Crespo B, Franco V, Gómez-Lorenzo MG, Jiménez-Díaz MB, Angulo-Barturen Í, Sanz LM, Gamo FJ.

Malar J. 2015 Nov 5;14:441. doi: 10.1186/s12936-015-0962-2.

Supplemental Content

Support Center